Revenue, 2025
USD 18.00 Bn
Forecast Year, 2034
USD 24.51 Bn
CAGR, 2025 - 2034
3.49%
Report Coverage
Worldwide
The global antifungal drugs market, valued at USD 18.00 billion in 2025, is projected to reach USD 24.51 billion by 2034, expanding at a CAGR of 3.49%, driven by rising fungal infections and growing healthcare awareness worldwide.
Antifungal Drugs Market Size Analysis
Antifungal Drugs Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Azoles | 3.31 | 3.42 | 3.53 | 3.64 | 3.75 | 3.87 | 3.99 | 4.12 | 4.25 | 4.38 |
| Echinocandins | 3.31 | 3.42 | 3.54 | 3.66 | 3.78 | 3.91 | 4.04 | 4.18 | 4.32 | 4.46 |
| Polyenes | 3.52 | 3.65 | 3.78 | 3.91 | 4.05 | 4.19 | 4.34 | 4.50 | 4.65 | 4.81 |
| Allylamines | 3.81 | 3.95 | 4.09 | 4.23 | 4.38 | 4.54 | 4.70 | 4.87 | 5.05 | 5.23 |
| Others | 4.05 | 4.20 | 4.35 | 4.51 | 4.68 | 4.86 | 5.04 | 5.23 | 5.42 | 5.63 |
Antifungal Drugs Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermatophytosis | 3.75 | 3.87 | 4.00 | 4.14 | 4.28 | 4.42 | 4.56 | 4.72 | 4.88 | 5.04 |
| Aspergillosis | 4.43 | 4.57 | 4.73 | 4.89 | 5.06 | 5.23 | 5.40 | 5.59 | 5.78 | 5.99 |
| Candidiasis | 4.61 | 4.77 | 4.94 | 5.11 | 5.29 | 5.48 | 5.66 | 5.86 | 6.07 | 6.29 |
| Others | 5.22 | 5.41 | 5.60 | 5.81 | 6.02 | 6.24 | 6.48 | 6.71 | 6.94 | 7.19 |
Antifungal Drugs Market Size By Dosage Form 2025 to 2034 (USD Billion)
| Dosage Form | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral Drugs | 3.91 | 4.04 | 4.18 | 4.31 | 4.45 | 4.60 | 4.76 | 4.93 | 5.09 | 5.25 |
| Ointments | 4.13 | 4.27 | 4.42 | 4.57 | 4.73 | 4.89 | 5.06 | 5.24 | 5.42 | 5.61 |
| Powders | 4.95 | 5.13 | 5.31 | 5.49 | 5.69 | 5.89 | 6.09 | 6.30 | 6.52 | 6.76 |
| Others | 5.01 | 5.19 | 5.38 | 5.58 | 5.78 | 5.99 | 6.20 | 6.42 | 6.65 | 6.89 |
Antifungal Drugs Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 5.18 | 5.35 | 5.53 | 5.72 | 5.92 | 6.12 | 6.33 | 6.54 | 6.77 | 6.99 |
| Retail Pharmacies | 5.91 | 6.11 | 6.32 | 6.54 | 6.77 | 7.00 | 7.24 | 7.49 | 7.75 | 8.02 |
| Others | 6.91 | 7.17 | 7.43 | 7.69 | 7.96 | 8.25 | 8.54 | 8.86 | 9.17 | 9.49 |
Antifungal Drugs Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.98 | 3.07 | 3.16 | 3.26 | 3.37 | 3.48 | 3.60 | 3.72 | 3.84 | 3.96 |
| Europe | 3.37 | 3.48 | 3.59 | 3.71 | 3.84 | 3.97 | 4.10 | 4.24 | 4.38 | 4.53 |
| Asia-Pacific | 3.76 | 3.89 | 4.03 | 4.16 | 4.30 | 4.45 | 4.60 | 4.75 | 4.92 | 5.10 |
| Latin America | 3.91 | 4.05 | 4.20 | 4.36 | 4.52 | 4.68 | 4.85 | 5.03 | 5.21 | 5.40 |
| Middle East and Africa | 3.99 | 4.14 | 4.30 | 4.46 | 4.62 | 4.79 | 4.96 | 5.15 | 5.33 | 5.52 |
Antifungal Drugs Market Size to Reach USD 24.51 Billion by 2034
The global antifungal drugs market size was estimated at USD 18.00 billion in 2025 and is projected to be worth around USD 24.51 billion by 2034,with a CAGR of 3.49%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com